Back to funds
View filing
Frazier Life Sciences Management, L.P.
Updated 6 days agoManaged by Frazier Life Sciences Management, L.P. • Latest filing Q3 2026
Portfolio value
$4B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $3.7B |
| Q1 2026 | $3.9B |
| Q2 2026 | $4.6B |
| Q3 2026 | $4B |
Top holdings
44 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $656.5M | 7.68M | 16.29% | — | |
| 2 | $461.8M | 18.99M | 11.46% | — | |
| 3 | $432.1M | 29.48M | 10.72% | — | |
| 4 | $389.9M | 6.65M | 9.67% | — | |
| 5 | $261M | 9.87M | 6.47% | — | |
| 6 | $143.6M | 5.28M | 3.56% | — | |
| 7 | $136.6M | 9.54M | 3.39% | — | |
| 8 | $130.1M | 391.3K | 3.23% | — | |
| 9 | $121.7M | 882.4K | 3.02% | — | |
| 10 | ? N/A ATTOVIA THERAPEUTICS INC | $120.8M | 7.05M | 3.00% | — |
| 11 | ? N/A BRAVEHEART BIO INC | $106.4M | 5.27M | 2.64% | — |
| 12 | $91M | 12.47M | 2.26% | — | |
| 13 | $75.3M | 2.33M | 1.87% | — | |
| 14 | $62.1M | 3.85M | 1.54% | — | |
| 15 | $61.6M | 7.61M | 1.53% | — | |
| 16 | $61.4M | 15.76M | 1.52% | — | |
| 17 | $61.2M | 934.9K | 1.52% | — | |
| 18 | $56.6M | 720.3K | 1.40% | — | |
| 19 | $52.4M | 2.74M | 1.30% | — | |
| 20 | $51.3M | 225.2K | 1.27% | — |